About 333,000 results
https://www.nasdaq.com/symbol/gildCommon Stock (GILD) Quote & Summary Data.
... (Gilead, we, our or us), incorporated in Delaware on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.
... Gilead's primary areas of ...
https://www.nasdaq.com/symbol/gild/dividend-historySee the upcoming ex dividend date and dividend history for Gilead Sciences, Inc.
(GILD). Stay alerted to dividend announcements for GILD and all the companies
you follow at NASDAQ.com.
https://finance.yahoo.com/q?s=GildView the basic GILD stock chart on Yahoo Finance. ... Can Gilead Sciences Inc's
(NASDAQ:GILD) ROE Continue To Surpass The Industry Average? Gilead
Sciences Inc (NASDAQ:GILD) delivered an ROE of 22.65% over the past 12
months, which is an impressive feat relative to its industry average of 17.87%
during the ...
https://seekingalpha.com/.../4158758-gilead-biktarvy-kill-sell-thesisMar 26, 2018 ... Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the U.S. Food and
Drug Administration (FDA) has approved Biktarvy® (bictegravir 50mg/
emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily
single tablet regimen (NYSE:STR) for the treatment of HIV-1 infection. Biktarvy ...
https://seekingalpha.com/.../4161287-ahead-curve-gilead-sciencesApr 5, 2018 ... For many readers, you may recognize my premise as a go-to for bulls for the last
2 years- HCV revenue declines don't matter as Gilead Sciences (GILD) is
undervalued even when only taking their other drugs and pipeline into account. If
you don't want to read yet another article hammering this point home, ...
https://www.bizjournals.com/.../gilead-sciences-gild-compensation- commuting.htmlMar 28, 2018 ... When Kevin Young returned to Gilead Sciences Inc. two years ago as chief
operating officer, the drug maker's board of directors granted him a unique
perquisite: picking up his commuting airfare. Through last year, the tab totaled
$221,799, according to Securities and Exchange Commission filings, ...
Real time Gilead Sciences (GILD) stock price quote, stock graph, news &
Rating: 5 - 3,688 votes
https://www.fool.com/.../04/.../is-gilead-sciences-inc-gild-a-buy.aspxApr 11, 2018 ... Gilead Sciences (NASDAQ:GILD) once was a favorite for biotech investors. That
hasn't been the case over the past couple of years, though. The big biotech fell
out of favor with investors as sales for its hepatitis C virus (HCV) drugs plunged,
dragging Gilead's overall revenue and earnings down in the ...
https://stocktwits.com/symbol/GILDGilead Sciences Inc. 1.29 (1.74%). Watch. DOW0.00% · S&P 5000.00% ·
NASDAQ0.00%. Trending Now. Watchlist. Sign up to StockTwits to save a
watchlist for easy access to your favorite stocks. Sign Up. or Login. About · Team ·
Careers · Press · Help · Blog · Developers · Best Practices · House Rules · Terms ·
Science research company
Gilead Sciences, Inc., commonly known as Gilead Sciences or Gilead, is an American biopharmaceutical company that researches, develops and commercializes drugs. Wikipedia
Headquarters: Foster City, CA
CEO: John F. Milligan (Mar 2016–)
Revenue: 26.11 billion USD (2017)
Founder: Michael L. Riordan
Founded: June 1987, Foster City, CA